KLC2 Protein (Transcript Variant 4) (Myc-DYKDDDDK Tag)

Produktnummer ABIN2724276

Produktdetails

Target: KLC2 (Kinesin Light Chain 2 (KLC2))

Protein-Typ: Recombinant

Proteineigenschaft: Transcript Variant 4

Spezies: Human

Quelle: HEK-293 Cells

Aufreinigungstag / Konjugat: Dieses KLC2 Protein ist gelabelt mit Myc-DYKDDDDK Tag.

Applikation: Antibody Production (AbP), Standard (STD)

Produktmerkmale:

• Recombinant human KLC2 (transcript variant 4) protein expressed in HEK293 cells.
• Produced with end-sequenced ORF clone

Reinheit: > 80 % as determined by SDS-PAGE and Coomassie blue staining

Anwendungsinformationen

Applikationshinweise: Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays

Kommentare:

The tag is located at the C-terminal.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 50 μg/mL

Buffer: 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.

Lagerung: -80 °C

Informationen zur Lagerung: Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.

Antigendetails

Target: KLC2 (Kinesin Light Chain 2 (KLC2))

Andere Bezeichnung: Klc2 (KLC2 Produkte)

Synonyme: MGC143149 Protein, wu:fc15b01 Protein, wu:fj62c06 Protein, zgc:162288 Protein, DKFZp459K0951 Protein, 8030455F02Rik Protein, AW212649 Protein, KLC 2 Protein, KLC-2 Protein, kinesin light chain 2 Protein, KLC2 Protein, klc2 Protein, Klc2 Protein

Hintergrund: The protein encoded by this gene is a light chain of kinesin, a molecular motor responsible for moving vesicles and organelles along microtubules. Defects in this gene are a cause of spastic paraplegia, optic atrophy, and neuropathy (SPOAN) syndrome.

Molekulargewicht: 68.8 kDa

NCBI Accession: NP_001128248